Noémie Kraaijpoel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Noémie Kraaijpoel has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
- Nick van Es
Department of Vascular Medicine, University of Amsterdam, Amsterdam UMC Location, Amsterdam, the Netherlands
3 shared publications - Arnaud Perrier
Department of General Internal Medicine, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland
2 shared publications D. Mark Courtney
Department of Emergency Medicine, The University of Texas Southwestern Medical Center, Dallas, Texas (D.M.C.)
2 shared publications- Frederikus Albertus Klok
Department of Medicine-Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands
2 shared publications Grégoire Le Gal
Department of Medicine, University of Ottawa, Ottawa Hospital Research Institute, Thrombosis Research Group, Ottawa, Ontario, Canada (G.L.G., P.S.W.)
2 shared publicationsHarry R. Büller
Department of Vascular Medicine, Amsterdam University Medical Center, location AMC, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands (N.K., N.v.E., H.R.B.)
2 shared publications
Latest Publications
- 5 February 2026
- Published by Wiley in Transplant Infectious Disease
- Vol. 28 (3) , e70181
Coxsackie A6 Virus Infection in a Kidney Transplant Recipient
- 5 February 2026
- Published by Wiley in Transplant Infectious Disease
- Vol. 28 (3) , e70181
Coxsackie A6 Virus Infection in a Kidney Transplant Recipient
- Open Access
- 8 September 2023
- Published by Elsevier in eClinicalMedicine
- Vol. 64, 102194
The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis: a systematic review and meta-analysis
- 8 September 2023
- Published by Elsevier in eClinicalMedicine
- Vol. 64, 102194
Open AccessThe risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis: a systematic review and meta-analysis
- Open Access
- 4 November 2022
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 6 (7) , e12834
Case‐fatality rate of major bleeding events in patients on dual antiplatelet therapy after percutaneous coronary intervention: A systematic review and meta‐analysis
- 4 November 2022
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 6 (7) , e12834
Open AccessCase‐fatality rate of major bleeding events in patients on dual antiplatelet therapy after percutaneous coronary intervention: A systematic review and meta‐analysis
- Top Cited Papers
- 1 February 2022
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 175 (2) , 244-255
Safety and Efficiency of Diagnostic Strategies for Ruling Out Pulmonary Embolism in Clinically Relevant Patient Subgroups
How diagnostic strategies for pulmonary embolism (PE) perform across clinical patient characteristics is unclear. In this individual-participant data meta-analysis, investigators pooled data from 2... Background: How diagnostic strategies for suspected pulmonary embolism (PE) perform in relevant patient subgroups defined by sex, age, cancer, and previous venous thromboembolism (VTE) is unknown. ...
- 1 February 2022
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 175 (2) , 244-255
Top Cited PapersSafety and Efficiency of Diagnostic Strategies for Ruling Out Pulmonary Embolism in Clinically Relevant Patient Subgroups
How diagnostic strategies for pulmonary embolism (PE) perform across clinical patient characteristics is unclear. In this individual-participant data meta-analysis, investigators pooled data from 2... Background: How diagnostic strategies for suspected pulmonary embolism (PE) perform in relevant patient subgroups defined by sex, age, cancer, and previous venous thromboembolism (VTE) is unknown. ...
- Open Access
- 25 January 2022
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 19 (1) , e1003905
Ruling out pulmonary embolism across different healthcare settings: A systematic review and individual patient data meta-analysis
Background: The challenging clinical dilemma of detecting pulmonary embolism (PE) in suspected patients is encountered in a variety of healthcare settings. We hypothesized that the optimal diagnostic approach to detect these patients in terms of safety and efficiency depends on underlying PE prevalence, case mix, and physician experience, overall reflected by the type of setting where patients are initially assessed. The objective of this study was to assess the capability of ruling out PE by available diagnostic strategies across all possible settings. Methods and findings: We performed a literature search (MEDLINE) followed by an individual patient data (IPD) meta-analysis (MA; 23 studies), including patients from self-referral emergency care (n = 12,612), primary healthcare clinics (n = 3,174), referred secondary care (n = 17,052), and hospitalized or nursing home patients (n = 2,410). Multilevel logistic regression was performed to evaluate diagnostic performance of the Wells and revised Geneva rules, both using fixed and adapted D-dimer thresholds to age or pretest probability (PTP), for the YEARS algorithm and for the Pulmonary Embolism Rule-out Criteria (PERC). All strategies were tested separately in each healthcare setting. Following studies done in this field, the primary diagnostic metrices estimated from the models were the “failure rate” of each strategy—i.e., the proportion of missed PE among patients categorized as “PE excluded” and “efficiency”—defined as the proportion of patients categorized as “PE excluded” among all patients. In self-referral emergency care, the PERC algorithm excludes PE in 21% of suspected patients at a failure rate of 1.12% (95% confidence interval [CI] 0.74 to 1.70), whereas this increases to 6.01% (4.09 to 8.75) in referred patients to secondary care at an efficiency of 10%. In patients from primary healthcare and those referred to secondary care, strategies adjusting D-dimer to PTP are the most efficient (range: 43% to 62%) at a failure rate ranging between 0.25% and 3.06%, with higher failure rates observed in patients referred to secondary care. For this latter setting, strategies adjusting D-dimer to age are associated with a lower failure rate ranging between 0.65% and 0.81%, yet are also less efficient (range: 33% and 35%). For all strategies, failure rates are highest in hospitalized or nursing home patients, ranging between 1.68% and 5.13%, at an efficiency ranging between 15% and 30%. The main limitation of the primary analyses was that the diagnostic performance of each strategy was compared in different sets of studies since the availability of items used in each diagnostic strategy differed across included studies; however, sensitivity analyses suggested that the findings were robust. Conclusions: The capability of safely and efficiently ruling out PE of available diagnostic strategies differs for different healthcare settings. The findings of this IPD MA help in determining the optimum diagnostic strategies for ruling out PE per healthcare setting, balancing the trade-off between failure rate and efficiency of each strategy.
- 25 January 2022
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 19 (1) , e1003905
Open AccessRuling out pulmonary embolism across different healthcare settings: A systematic review and individual patient data meta-analysis
Background: The challenging clinical dilemma of detecting pulmonary embolism (PE) in suspected patients is encountered in a variety of healthcare settings. We hypothesized that the optimal diagnostic approach to detect these patients in terms of safety and efficiency depends on underlying PE prevalence, case mix, and physician experience, overall reflected by the type of setting where patients are initially assessed. The objective of this study was to assess the capability of ruling out PE by available diagnostic strategies across all possible settings. Methods and findings: We performed a literature search (MEDLINE) followed by an individual patient data (IPD) meta-analysis (MA; 23 studies), including patients from self-referral emergency care (n = 12,612), primary healthcare clinics (n = 3,174), referred secondary care (n = 17,052), and hospitalized or nursing home patients (n = 2,410). Multilevel logistic regression was performed to evaluate diagnostic performance of the Wells and revised Geneva rules, both using fixed and adapted D-dimer thresholds to age or pretest probability (PTP), for the YEARS algorithm and for the Pulmonary Embolism Rule-out Criteria (PERC). All strategies were tested separately in each healthcare setting. Following studies done in this field, the primary diagnostic metrices estimated from the models were the “failure rate” of each strategy—i.e., the proportion of missed PE among patients categorized as “PE excluded” and “efficiency”—defined as the proportion of patients categorized as “PE excluded” among all patients. In self-referral emergency care, the PERC algorithm excludes PE in 21% of suspected patients at a failure rate of 1.12% (95% confidence interval [CI] 0.74 to 1.70), whereas this increases to 6.01% (4.09 to 8.75) in referred patients to secondary care at an efficiency of 10%. In patients from primary healthcare and those referred to secondary care, strategies adjusting D-dimer to PTP are the most efficient (range: 43% to 62%) at a failure rate ranging between 0.25% and 3.06%, with higher failure rates observed in patients referred to secondary care. For this latter setting, strategies adjusting D-dimer to age are associated with a lower failure rate ranging between 0.65% and 0.81%, yet are also less efficient (range: 33% and 35%). For all strategies, failure rates are highest in hospitalized or nursing home patients, ranging between 1.68% and 5.13%, at an efficiency ranging between 15% and 30%. The main limitation of the primary analyses was that the diagnostic performance of each strategy was compared in different sets of studies since the availability of items used in each diagnostic strategy differed across included studies; however, sensitivity analyses suggested that the findings were robust. Conclusions: The capability of safely and efficiently ruling out PE of available diagnostic strategies differs for different healthcare settings. The findings of this IPD MA help in determining the optimum diagnostic strategies for ruling out PE per healthcare setting, balancing the trade-off between failure rate and efficiency of each strategy.
- 16 September 2021
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 19 (11) , 2791-2800
The prognostic value of respiratory symptoms and performance status in ambulatory cancer patients and unsuspected pulmonary embolism; analysis of an international, prospective, observational cohort study
- 16 September 2021
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 19 (11) , 2791-2800
The prognostic value of respiratory symptoms and performance status in ambulatory cancer patients and unsuspected pulmonary embolism; analysis of an international, prospective, observational cohort study
- Open Access
- 11 February 2020
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (2) , e0228788
Diagnostic accuracy of three ultrasonography strategies for deep vein thrombosis of the lower extremity: A systematic review and meta-analysis
Compression ultrasonography (CUS) is the first-line imaging test in the diagnostic management of suspected deep vein thrombosis (DVT) of the lower extremity. Three CUS strategies are used in clinical practice. However, their relative diagnostic accuracy is uncertain. This systematic review and meta-analysis aimed to summarize and compare the diagnostic accuracy of single limited, serial limited, and whole-leg CUS for DVT. MEDLINE, Embase, and CENTRAL were searched from January 1st, 1989 to July 23rd, 2019 for studies assessing at least one of the CUS strategies in adults with suspected DVT of the lower extremity, using clinical follow-up for venous thromboembolism or contrast venography as the reference standard. Study selection, data extraction, and risk of bias assessment were performed in duplicate by independent authors. A bivariate random-effects model was used to compute diagnostic accuracy summary estimates. Forty studies (n = 21,250) were included. The venous thromboembolic event rate after a negative CUS (failure rate) of single limited (1.4%; 95% CI, 0.83–2.5), serial limited (1.9%; 95% CI, 1.4–2.5), and whole-leg CUS (1.0%; 95% CI, 0.6–1.6) did not differ significantly. The proportion of positive results was lower with single limited CUS, as was DVT prevalence in this group. The failure rates of single limited, serial limited, and whole-leg CUS for DVT appeared to be quite comparable. The relative failure rate of single limited CUS remains uncertain, as the DVT prevalence was lower in these studies. Therefore, this CUS strategy may only be safe in a selected group of low-risk patients. Preference for one of the strategies may be based on pretest probability assessment, feasibility, expertise, and perceived clinical relevance of isolated distal DVT.
- 11 February 2020
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (2) , e0228788
Open AccessDiagnostic accuracy of three ultrasonography strategies for deep vein thrombosis of the lower extremity: A systematic review and meta-analysis
Compression ultrasonography (CUS) is the first-line imaging test in the diagnostic management of suspected deep vein thrombosis (DVT) of the lower extremity. Three CUS strategies are used in clinical practice. However, their relative diagnostic accuracy is uncertain. This systematic review and meta-analysis aimed to summarize and compare the diagnostic accuracy of single limited, serial limited, and whole-leg CUS for DVT. MEDLINE, Embase, and CENTRAL were searched from January 1st, 1989 to July 23rd, 2019 for studies assessing at least one of the CUS strategies in adults with suspected DVT of the lower extremity, using clinical follow-up for venous thromboembolism or contrast venography as the reference standard. Study selection, data extraction, and risk of bias assessment were performed in duplicate by independent authors. A bivariate random-effects model was used to compute diagnostic accuracy summary estimates. Forty studies (n = 21,250) were included. The venous thromboembolic event rate after a negative CUS (failure rate) of single limited (1.4%; 95% CI, 0.83–2.5), serial limited (1.9%; 95% CI, 1.4–2.5), and whole-leg CUS (1.0%; 95% CI, 0.6–1.6) did not differ significantly. The proportion of positive results was lower with single limited CUS, as was DVT prevalence in this group. The failure rates of single limited, serial limited, and whole-leg CUS for DVT appeared to be quite comparable. The relative failure rate of single limited CUS remains uncertain, as the DVT prevalence was lower in these studies. Therefore, this CUS strategy may only be safe in a selected group of low-risk patients. Preference for one of the strategies may be based on pretest probability assessment, feasibility, expertise, and perceived clinical relevance of isolated distal DVT.